Oruka Therapeutics, Inc. Quarterly Return On Equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Oruka Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q3 2024.
  • Oruka Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was -62.9 %, a 362% decline year-over-year.
  • Oruka Therapeutics, Inc. annual Return On Equity for 2023 was -13.8 %, a 38.4% increase from 2022.
  • Oruka Therapeutics, Inc. annual Return On Equity for 2022 was -22.4 %, a 32% increase from 2021.
  • Oruka Therapeutics, Inc. annual Return On Equity for 2021 was -32.9 %, a 4% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -62.9 -49.3 -362% Jul 1, 2024 Sep 30, 2024
Q2 2024 -275 -259 -1681% Apr 1, 2024 Jun 30, 2024
Q1 2024 -22.4 -3.57 -19% Jan 1, 2024 Mar 31, 2024
Q4 2023 -13.8 +8.59 +38.4% Oct 1, 2023 Dec 31, 2023
Q3 2023 -13.6 +17.3 +56% Jul 1, 2023 Sep 30, 2023
Q2 2023 -15.4 +18.1 +54% Apr 1, 2023 Jun 30, 2023
Q1 2023 -18.8 +15.3 +44.8% Jan 1, 2023 Mar 31, 2023
Q4 2022 -22.4 +10.5 +32% Oct 1, 2022 Dec 31, 2022
Q3 2022 -30.9 +1.7 +5.21% Jul 1, 2022 Sep 30, 2022
Q2 2022 -33.5 -4.87 -17% Apr 1, 2022 Jun 30, 2022
Q1 2022 -34.1 -5.21 -18% Jan 1, 2022 Mar 31, 2022
Q4 2021 -32.9 +1.37 +4% Oct 1, 2021 Dec 31, 2021
Q3 2021 -32.6 -1.34 -4.28% Jul 1, 2021 Sep 30, 2021
Q2 2021 -28.7 +32 +52.7% Apr 1, 2021 Jun 30, 2021
Q1 2021 -28.9 +35.5 +55.1% Jan 1, 2021 Mar 31, 2021
Q4 2020 -34.3 +32.3 +48.5% Oct 1, 2020 Dec 31, 2020
Q3 2020 -31.3 +42.1 +57.3% Jul 1, 2020 Sep 30, 2020
Q2 2020 -60.6 +21.8 +26.5% Apr 1, 2020 Jun 30, 2020
Q1 2020 -64.4 +27.7 +30% Jan 1, 2020 Mar 31, 2020
Q4 2019 -66.6 +28 +29.6% Oct 1, 2019 Dec 31, 2019
Q3 2019 -73.3 +39.3 +34.9% Jul 1, 2019 Sep 30, 2019
Q2 2019 -82.4 +38.3 +31.7% Apr 1, 2019 Jun 30, 2019
Q1 2019 -92.1 +41.9 +31.3% Jan 1, 2019 Mar 31, 2019
Q4 2018 -94.6 +34.2 +26.6% Oct 1, 2018 Dec 31, 2018
Q3 2018 -113 -5.68 -5.31% Jul 1, 2018 Sep 30, 2018
Q2 2018 -121 -28.6 -31% Apr 1, 2018 Jun 30, 2018
Q1 2018 -134 -63.7 -90.7% Jan 1, 2018 Mar 31, 2018
Q4 2017 -129 -71.2 -124% Oct 1, 2017 Dec 31, 2017
Q3 2017 -107 -59.7 -126% Jul 1, 2017 Sep 30, 2017
Q2 2017 -92.1 -54.7 -146% Apr 1, 2017 Jun 30, 2017
Q1 2017 -70.2 -38.9 -124% Jan 1, 2017 Mar 31, 2017
Q4 2016 -57.6 -23.7 -70% Oct 1, 2016 Dec 31, 2016
Q3 2016 -47.3 -8.29 -21.3% Jul 1, 2016 Sep 30, 2016
Q2 2016 -37.4 +9.78 +20.7% Apr 1, 2016 Jun 30, 2016
Q1 2016 -31.4 +32 +50.5% Jan 1, 2016 Mar 31, 2016
Q4 2015 -33.9 +19.3 +36.3% Oct 1, 2015 Dec 31, 2015
Q3 2015 -39 +15.5 +28.4% Jul 1, 2015 Sep 30, 2015
Q2 2015 -47.2 +3.42 +6.76% Apr 1, 2015 Jun 30, 2015
Q1 2015 -63.4 -19.7 -44.9% Jan 1, 2015 Mar 31, 2015
Q4 2014 -53.2 -4.8 -9.91% Oct 1, 2014 Dec 31, 2014
Q3 2014 -54.5 -11.1 -25.7% Jul 1, 2014 Sep 30, 2014
Q2 2014 -50.6 +4.27 +7.78% Apr 1, 2014 Jun 30, 2014
Q1 2014 -43.7 +81.9 +65.2% Jan 1, 2014 Mar 31, 2014
Q4 2013 -48.4 +77.5 +61.5% Oct 1, 2013 Dec 31, 2013
Q3 2013 -43.3 +80.2 +64.9% Jul 1, 2013 Sep 30, 2013
Q2 2013 -54.9 +70.8 +56.4% Apr 1, 2013 Jun 30, 2013
Q1 2013 -126 -47.5 -60.8% Jan 1, 2013 Mar 31, 2013
Q4 2012 -126 Oct 1, 2012 Dec 31, 2012
Q3 2012 -124 Jul 1, 2012 Sep 30, 2012
Q2 2012 -126 Apr 1, 2012 Jun 30, 2012
Q1 2012 -78.2 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.